Skip to Content

RAN 300 (Ranitidine Hydrochloride 300 mg)

Pill with imprint RAN 300 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Aurobindo Pharma Limited.

Ranitidine is used in the treatment of duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RAN 300

Ranitidine Hydrochloride

Imprint
RAN 300
Strength
300 mg
Color
Brown
Size
19.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma Limited
Manufacturer
Saraca Laboratories Limited
National Drug Code (NDC)
59651-0145
Inactive Ingredients
FD&C Blue No. 1, FD&C Red No. 40, FD&C Yellow No. 6, magnesium stearate, microcrystalline cellulose, potassium hydroxide, propylene glycol, shellac, sodium lauryl sulfate, sodium starch glycolate type A potato, ammonia, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "RAN 300"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.